| Lastest Insider Transactions Of Cyteir Therapeutics, Inc. ( CYT ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CYT | Cyteir Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-03-20 | Buy | 170,589 | 2.95 | 503,238 | 2024-03-25 11:05:47 |
| CYT | Cyteir Therapeutics, Inc. | Gaiero David G | Chief Financial Officer | 2024-02-29 | Option Exercise | 10,358 | 1.69 | 17,473 | 2024-03-05 18:11:17 |
| CYT | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD | President and CEO | 2024-02-29 | Option Exercise | 21,448 | 1.63 | 35,004 | 2024-03-05 18:10:05 |
| CYT | Cyteir Therapeutics, Inc. | George Jean | Directior | 2024-02-14 | Option Exercise | 14,150 | 1.69 | 23,914 | 2024-02-16 16:00:12 |
| CYT | Cyteir Therapeutics, Inc. | Sands Stephen H. | Directior | 2024-02-09 | Option Exercise | 12,129 | 1.69 | 20,498 | 2024-02-14 16:01:23 |
| CYT | Cyteir Therapeutics, Inc. | THERO JOHN F | Directior | 2024-02-08 | Option Exercise | 12,828 | 1.69 | 21,679 | 2024-02-12 16:00:17 |
| CYT | Cyteir Therapeutics, Inc. | Zakrzewski Joseph S | Directior | 2024-02-06 | Option Exercise | 14,150 | 1.69 | 23,914 | 2024-02-08 16:11:10 |
| CYT | Cyteir Therapeutics, Inc. | Gaiero David G | Chief Financial Officer | 2023-12-11 | Option Exercise | 3,993 | 1.69 | 6,732 | 2023-12-14 16:00:15 |
| CYT | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD | President and CEO | 2023-12-11 | Option Exercise | 8,840 | 1.55 | 13,697 | 2023-12-14 16:00:12 |
| CYT | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD | President and CEO | 2023-11-20 | Option Exercise | 84,637 | 1.53 | 129,366 | 2023-11-22 13:48:57 |
| CYT | Cyteir Therapeutics, Inc. | Gaiero David G | Chief Financial Officer | 2023-11-20 | Option Exercise | 73,940 | 1.68 | 124,433 | 2023-11-22 13:47:57 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-07-19 | Sell | 101,900 | 2.75 | 280,387 | 2023-07-20 20:01:11 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-07-14 | Sell | 38,600 | 2.75 | 106,024 | 2023-07-18 20:27:47 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-06-30 | Sell | 200,937 | 2.63 | 529,288 | 2023-07-03 18:29:46 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-06-26 | Sell | 40,415 | 1.78 | 71,794 | 2023-06-28 21:35:43 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-06-21 | Sell | 13,298 | 1.95 | 25,870 | 2023-06-23 19:17:26 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-06-15 | Sell | 16,729 | 2.03 | 34,019 | 2023-06-20 17:53:44 |
| CYT | Cyteir Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | 2023-06-12 | Sell | 6,398 | 2.10 | 13,423 | 2023-06-14 20:18:05 |
| CYT | Cyteir Therapeutics, Inc. | Gaiero David G | Chief Financial Officer | 2021-12-20 | Option Exercise | 4,100 | 1.68 | 6,888 | 2023-02-07 16:38:17 |
| CYT | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD | President and CEO | 2022-12-21 | Option Exercise | 136,782 | 1.07 | 146,060 | 2022-12-23 16:47:30 |
| CYT | Cyteir Therapeutics, Inc. | Zakrzewski Joseph S | Directior | 2022-12-07 | Buy | 21,202 | 1.30 | 27,563 | 2022-12-08 17:09:18 |
